MedPath

Programmed Intermittent Bolus Infusion of Thoracic Paravertebral Block for Hepatectomy

Not Applicable
Completed
Conditions
Paravertebral Block
Hepatectomy
Postoperative Recovery
Analgesia
Interventions
Procedure: Paravertebral block-saline
Procedure: Paravertebral block-ropivacaine
Drug: patient controlled analgesia with morphine
Registration Number
NCT04304274
Lead Sponsor
Cui Xulei
Brief Summary

Hepatectomy induces moderate to severe postoperative pain. Patient-controlled intravenous analgesia has been used in many medical centers for post-hepatectomy analgesia, but the effects are limited and often cause undesirable adverse effects.

Regional Block has been used for postoperative analgesia in many surgeries. Some studies suggest that regional analgesia has an opioid-sparing effect and can reduce the incidence of chronic pain. Also, the programmed intermittent bolus infusion is better than continuous infusion, with less analgesic consumption and fewer adverse effects.

Studies on the early and late postoperative analgesia and recovery effects of paravertebral block for open hepatectomy are scarce. Therefore, the investigators aim to conduct a prospective, randomized, subject and assessor-blinded, parallel-group, placebo-controlled study to test the hypothesis that the programmed intermittent bolus infusion of right thoracic paravertebral block reduces postoperative intravenous analgesic use and pain scores and improved patients' satisfaction.

Detailed Description

This study aims to compare the early postoperative morphine consumptions, pain scores, rescue analgesics, adverse effects and recovery indices, and the late postoperative life quality between patients with and without paravertebral block.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
76
Inclusion Criteria
  • Age 18-70 yrs
  • American Society of Anesthesiologists physical statusⅠ-Ⅲ
  • Undergo hepatectomy with J-shape subcostal incision
  • Informed consent
Exclusion Criteria
  • A known allergy to the drugs being used
  • Coagulopathy, on anticoagulants
  • Analgesics intake, history of substance abuse
  • Participating in the investigation of another experimental agent
  • Unable to cooperate, eg. inability to properly describe postoperative pain to investigators

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PTPVB-salinepatient controlled analgesia with morphineProgrammed intermittent bolus infusion of a thoracic paravertebral block with saline and patient-controlled analgesia with morphine
PTPVB-ropivacainepatient controlled analgesia with morphineProgrammed intermittent bolus infusion of a thoracic paravertebral block with ropivacaine and patient-controlled analgesia with morphine
PTPVB-salineParavertebral block-salineProgrammed intermittent bolus infusion of a thoracic paravertebral block with saline and patient-controlled analgesia with morphine
PTPVB-ropivacaineParavertebral block-ropivacaineProgrammed intermittent bolus infusion of a thoracic paravertebral block with ropivacaine and patient-controlled analgesia with morphine
Primary Outcome Measures
NameTimeMethod
Postoperative 48hrs morphinePostoperative 48 hours

Cumulate morphine consumption 48 hours after hepatectomy

Secondary Outcome Measures
NameTimeMethod
Sevoflurane concentrationDuring the operation

The average value of the sevoflurane concentration during the operation measured at 10 minutes interval

Operation timeDuring the operation

Time from the start to the end of the operation

The pain scores(at rest and with cough) determined by the numeric rating scalePostoperative 0, 2, 4, 12, 24 and 48 hours

NRS is an internationally recognized pain scale with 11 points ranging from 0 to 10 points, with 0 defined as no pain and 10 defined as the worst pain imaginable.

Postoperative recovery indicesPostoperative 48 hours

Postoperative recovery indices including drowsiness, thirsty, cold feeling, cognitive decline and shiver evaluated using a 0-3 points Likert scale, with 0 defined as none, 1 defined as mild, 2 defined as moderate and 3 defined as severe.

Intraoperative medication doseDuring the operation

Doses of fentanyl, ephedrine, atrophin, phylepherine and urapidil used during the operation

Postoperative morphine consumptionPostoperative 2, 4, 12, 24hours

Cumulative morphine consumption at 2, 4, 12, 24 hours after hepatectomy

Mean blood pressureDuring the operation

The average value of the mean blood pressure (=1/3 systolic pressure + 2/3 diastolic pressure) during the operation measured at 10 minutes interval.

Fluid volumesDuring the operation

Fluid volumes including volumes of crystalloid, colloid, red blood cells, plasma, platelet, Urine and hemorrhage.

Rescue analgesiaPostoperative 0-48hours

Times of rescue analgesia

Awake and extubation timeAt the end of the operation

Time from stop of sevoflurane use to patient awake and extubation.

Adverse effectsPostoperative 0-48 hours

Adverse effects of morphine including nausea, vomiting, pruritus and respiratory depression, bowel movement and Foley catheter removal.

Chronic recovery dataPostoperative 3 months

Chronic recovery data including incidence of pain, numbness, hypoesthesia and sleep disorder

Chronic pain characteristicsPostoperative 3 months

Incidence of difference types of pain including throbbing, aching, pricking and stabbing.

Heart rateDuring the operation

The average value of the heart rate during the operation measured at 10 minutes interval

Length of hospital stayTwo weeks after hospital discharge

Number of in-hospital days from admission to discharge

Satisfaction indicesPostoperative 48 hours

Emergence, analgesia and overall satisfaction evaluated using a 1-5 points Likert scale, with 1 defined as very unsatisfied, 2 defined as unsatisfied, 3 defined as no comments, 4 defined as satisfied and 5 defined as very satisfied.

Chronic pain NRS scorePostoperative 3 months

NRS is an internationally recognised pain scale with 11 points ranging from 0 to 10 points, with 0 defined as no pain and 10 defined as the worst pain imaginable.

Trial Locations

Locations (1)

Peking Union Medical College Hospital

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath